Ironwood(IRWD)
搜索文档
Ironwood(IRWD) - 2022 Q4 - Earnings Call Presentation
2023-02-16 23:09
Ironwood Q4 and FY 2022 Investor Update February 16, 2023 . Ironwood Safe Harbor Statement This presentation contains forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, including statements about our ability to execute on our vision; our strategy, business, financial position and operations, including with respect to our strategic priorities; the demand, development, commercial availability and commercial potential of linaclotide and the driv ...
Ironwood Pharmaceuticals (IRWD) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- Slideshow
2023-01-13 00:19
Leading in GI through Growth and Innovation J.P. Morgan Healthcare Conference | January 11, 2023 Presented by Tom McCourt CEO, Ironwood Pharmaceuticals, Inc. Nasdaq: IRWD Safe Harbor Statement 2 This presentation contains forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, including statements about our ability to execute on our vision; our strategy, business, financial position and operations, including with respect to our strategic prioritie ...
Ironwood(IRWD) - 2022 Q3 - Earnings Call Transcript
2022-11-04 00:07
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2022 Results Conference Call November 3, 2022 8:30 AM ET Company Participants Tom McCourt - Chief Executive Officer Mike Shetzline - Chief Medical Officer Sravan Emany - Chief Financial Officer Matt Roache - Director of Investor Relations Conference Call Participants Boris Peaker - Cowen Daniel Wolle - JPMorgan Tim Chiang - Capital One Operator Hello. My name is Lisa, and I will be your conference operator today. At this time, I would like to welcome everyone ...
Ironwood(IRWD) - 2022 Q2 - Earnings Call Transcript
2022-08-06 15:17
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Â Company Representatives Tom McCourt - Chief Executive Officer Mike Shetzline - Chief Medical Officer Sravan Emany - Chief Financial Officer Matt Roache - Director of Investor Relations Conference Call Participants David Amsellem - Piper Sandler Operator Good morning. My name is Stephanie, and I will be your conference operator today. At this time, I would like to welcome everyone to the Ironwood Pharmac ...
Ironwood(IRWD) - 2022 Q1 - Earnings Call Transcript
2022-05-08 15:58
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2022 Earnings Conference Call May 5, 2022 8:30 AM ET Company Participants Matt Roache - Director, Investor Relations Tom McCourt - Chief Executive Officer Mike Shetzline - Chief Medical Officer Sravan Emany - Chief Financial Officer Conference Call Participants Hannah Monigatti - JPMorgan David Amsellem - Piper Sandler Tim Chiang - Northland Capital Markets Boris Peaker - Cowen and Company Operator Good morning. My name is Joseph and I will be your conference ...
Ironwood(IRWD) - 2021 Q4 - Earnings Call Transcript
2022-02-17 23:55
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2021 Earnings Conference Call February 17, 2022 8:30 AM ET Company Participants Matt Roache - Director of IR Thomas McCourt - CEO Michael Shetzline - CMO and Head of R&D Sravan K. Emany - CFO Conference Call Participants Boris Peaker - Cowen & Company Eric Joseph - JPMorgan Timothy Chiang - Northland Capital Unidentified Analyst - Wells Fargo Operator Ladies and gentlemen, good morning. My name is Abby and I will be your conference operator today. At this time ...
Ironwood(IRWD) - 2021 Q4 - Earnings Call Presentation
2022-02-17 21:08
| --- | --- | --- | |---------------------------|-------|-------| | | | | | | | | | Ironwood Q4 and Full Year | | | | | | | | | | | | 2021 Investor Update | | | | February 17, 2022 | | | Ironwood Introduction Matt Roache Safe Harbor Statement This presentation contains forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, including statements about our ability to execute well against our strategic priorities; the Company's strategy, business, fi ...
Ironwood Pharmaceuticals (IRWD) presents at JP Morgan 40th Annual Virtual Healthcare Conference (Slideshow)
2022-01-15 02:01
Leading in GI through Growth and Innovation J.P. Morgan Healthcare Conference January 12, 2022 PRESENTED BY Tom McCourt, CEO Ironwood Pharmaceuticals, Inc. Safe Harbor Statement 2 This presentation contains forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, including statements about our ability to execute on our vision and mission; our strategy, business, financial position and operations, including with respect to maximizing LINZESS® (linac ...
Ironwood(IRWD) - 2021 Q3 - Earnings Call Transcript
2021-11-07 02:04
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2021 Results Conference Call November 4, 2021 8:30 AM ET Company Participants Matt Roache - Director of Investor Relations Tom McCourt - Chief Executive Officer Mike Shetzline - Chief Medical Officer Jason Rickard - Chief Operating Officer Conference Call Participants Hannah Adeoye - JPMorgan David Lebowitz - Morgan Stanley Tim Chiang - Northland Capital Operator Good morning. My name is Rob, and I will be your conference operator today. At this time, I would ...
Ironwood(IRWD) - 2021 Q3 - Earnings Call Presentation
2021-11-05 04:30
| --- | --- | |------------------|-------| | | | | | | | | | | | | | | | | Ironwood Q3 2021 | | | | | | Earnings Update | | | November 4, 2021 | | Ironwood Introduction Matt Roache Safe Harbor Statement This presentation contains forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, including statements about our ability to execute on our vision and mission; our strategy, business, financial position and operations, including with respect to max ...